This HTML5 document contains 97 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dctermshttp://purl.org/dc/terms/
dbohttp://dbpedia.org/ontology/
foafhttp://xmlns.com/foaf/0.1/
n22https://web.archive.org/web/20060301044622/http:/www.harkin.senate.gov/
n9https://www.govinfo.gov/content/pkg/USCODE-2019-title42/pdf/
n20http://www.gallatinnewsexaminer.com/apps/pbcs.dll/article%3FAID=/20060209/NEWS02/602090405/1309/
n14https://global.dbpedia.org/id/
dbthttp://dbpedia.org/resource/Template:
rdfshttp://www.w3.org/2000/01/rdf-schema#
n21http://jurist.law.pitt.edu/paperchase/2006/02/
n23http://www.cidrap.umn.edu/cidrap/content/influenza/biz-plan/news/
freebasehttp://rdf.freebase.com/ns/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n6https://web.archive.org/web/20060629171751/http:/www.slweekly.com/editorial/2006/
n16http://clerk.house.gov/evs/2005/
owlhttp://www.w3.org/2002/07/owl#
wikipedia-enhttp://en.wikipedia.org/wiki/
dbphttp://dbpedia.org/property/
dbchttp://dbpedia.org/resource/Category:
provhttp://www.w3.org/ns/prov#
xsdhhttp://www.w3.org/2001/XMLSchema#
n13https://www.senate.gov/legislative/LIS/roll_call_lists/
wikidatahttp://www.wikidata.org/entity/
goldhttp://purl.org/linguistics/gold/
dbrhttp://dbpedia.org/resource/
n15http://www.smmirror.com/MainPages/

Statements

Subject Item
dbr:Public_Readiness_and_Emergency_Preparedness_Act
rdf:type
dbo:FootballMatch
rdfs:label
Public Readiness and Emergency Preparedness Act
rdfs:comment
The Public Readiness and Emergency Preparedness Act (PREPA), passed by the United States Congress and signed into law by President of the United States George W. Bush in December 2005 (as part of Pub.L. 109–148 (text) (PDF)), is a controversial tort liability shield intended to protect vaccine manufacturers from financial risk in the event of a declared public health emergency. The part of PREPA that actually affords such protection is now codified at 42 U.S.C. § 247d-6d. The act specifically affords to drug makers immunity from actions related to the manufacture, testing, development, distribution, administration and use of medical countermeasures against chemical, biological, radiological and nuclear agents of terrorism, epidemics, and pandemics. PREPA strengthens and consolidates the ov
dcterms:subject
dbc:Acts_of_the_109th_United_States_Congress dbc:Disaster_preparedness_in_the_United_States dbc:Vaccination_in_the_United_States dbc:Drug_policy_of_the_United_States dbc:United_States_federal_health_legislation dbc:Vaccination_law
dbo:wikiPageID
4136457
dbo:wikiPageRevisionID
1101851985
dbo:wikiPageWikiLink
dbr:Dennis_Hastert dbr:George_W._Bush_Administration dbr:Tort dbr:Health_and_Human_Services dbr:Thimerosal dbr:Gannett_News_Service dbr:United_States_Congress dbr:Eagle_Forum dbr:United_States_Senator dbr:President_of_the_United_States dbr:Public_health dbc:Acts_of_the_109th_United_States_Congress dbr:Vaccine_injury dbr:United_States_Constitution dbr:Federal_Food,_Drug,_and_Cosmetic_Act dbr:Appropriations_bill_(United_States) dbr:Food_and_Drug_Administration dbr:Derivative_suit dbr:Pharmaceutical dbr:Vaccine dbr:Lobbying dbr:United_States_District_Court_for_the_District_of_Columbia dbr:United_States_House_of_Representatives dbr:Nursing_home_care_in_the_United_States dbr:Bioterrorism dbr:Bill_Frist dbr:A-CHAMP dbr:United_States_Secretary_of_Health_and_Human_Services dbc:Disaster_preparedness_in_the_United_States dbr:Ethylmercury dbr:Nathan_Deal dbr:Conference_report dbr:Ted_Kennedy dbr:Salt_Lake_City_Weekly dbr:U.S._Department_of_Defense dbr:Epidemic dbr:Disease dbr:George_W._Bush dbr:University_of_Pittsburgh dbr:Public_Citizen dbr:Vaccines_for_the_New_Millennium_Act dbr:Pandemic dbc:Vaccination_in_the_United_States dbc:Drug_policy_of_the_United_States dbr:Influenza dbr:Complaint dbc:United_States_federal_health_legislation dbr:Jurist_Legal_News_&_Research dbr:Santa_Monica_Mirror dbr:Guillain–Barré_syndrome dbc:Vaccination_law dbr:COVID-19_pandemic_in_the_United_States
dbo:wikiPageExternalLink
n6:cityweek_1_2006-02-09.cfm n9:USCODE-2019-title42-chap12-front.pdf n13:roll_call_vote_cfm.cfm%3Fcongress=109&session=1&vote=00366 n15:DisplayArticleDetails.asp%3Feid=2871 n16:roll669.xml n20:MTCN04 n21:vaccine-liability-law-changes-proposed.php n22:news.cfm%3Fid=251591 n23:dec2805liability.html
owl:sameAs
wikidata:Q7257520 n14:4th4j freebase:m.0bl17r
dbp:wikiPageUsesTemplate
dbt:Usc dbt:Infobox_U.S._legislation dbt:Reflist dbt:Uspl dbt:Usstat dbt:Wikisource dbt:Vaccines dbt:No_footnotes dbt:Short_description
dbp:citePublicLaw
109
dbp:effectiveDate
December 2005
dbp:publicLawUrl
n9:USCODE-2019-title42-chap12-front.pdf
dbp:shorttitle
Public Readiness and Emergency Preparedness Act
dbp:enactedBy
109
dbp:nickname
PREPA
dbo:abstract
The Public Readiness and Emergency Preparedness Act (PREPA), passed by the United States Congress and signed into law by President of the United States George W. Bush in December 2005 (as part of Pub.L. 109–148 (text) (PDF)), is a controversial tort liability shield intended to protect vaccine manufacturers from financial risk in the event of a declared public health emergency. The part of PREPA that actually affords such protection is now codified at 42 U.S.C. § 247d-6d. The act specifically affords to drug makers immunity from actions related to the manufacture, testing, development, distribution, administration and use of medical countermeasures against chemical, biological, radiological and nuclear agents of terrorism, epidemics, and pandemics. PREPA strengthens and consolidates the oversight of litigation against pharmaceutical companies under the purview of the secretary of Health and Human Services (HHS). PREPA provides $3.8 billion for pandemic influenza preparedness to protect public health in the case of a pandemic disease outbreak. Vaccine manufacturers lobbied for the legislation, which would effectively preempt state vaccine safety laws in the case of an emergency declaration by HHS, by making clear they would not produce new vaccines unless the legislation was enacted. Wikisource has original text related to this article:Public Readiness and Emergency Preparedness Act During and in the aftermath of the 2020–21 COVID-19 pandemic in the United States, PREPA is being invoked in a variety of lawsuits, many involving skilled nursing or assisted living facilities where COVID-19 countermeasures including the administration or non-administration of vaccines is said to have resulted in or contributed to resident deaths. Although PREPA was around for more than 15 years, prior to COVID-19, the act's defensive application in litigation was not widespread, but now the application of the act is being included more frequently in a variety of COVID-19 related lawsuits, including Shareholder Derivative Litigation.
dbp:colloquialacronym
PREPA
dbp:longtitle
Public Readiness and Emergency Preparedness Act
gold:hypernym
dbr:Shield
prov:wasDerivedFrom
wikipedia-en:Public_Readiness_and_Emergency_Preparedness_Act?oldid=1101851985&ns=0
dbo:wikiPageLength
13916
foaf:isPrimaryTopicOf
wikipedia-en:Public_Readiness_and_Emergency_Preparedness_Act